US 12,262,726 B2
Protein-based therapeutic nutritional products and methods of using same
Khalid Mentak, San Ramon, CA (US); Fred Jewett, Pleasanton, CA (US); and Shahmard Maziar Ghorbani, Alamo, CA (US)
Assigned to ADVANCE INTERNATIONAL INC., Livermore, CA (US)
Filed by Advance International Inc., Livermore, CA (US)
Filed on Jan. 22, 2021, as Appl. No. 17/155,664.
Application 17/155,664 is a continuation of application No. PCT/US2019/043120, filed on Jul. 23, 2019.
Claims priority of provisional application 62/702,091, filed on Jul. 23, 2018.
Prior Publication US 2021/0386105 A1, Dec. 16, 2021
Int. Cl. A23L 33/185 (2016.01); A23L 33/00 (2016.01); A23L 33/115 (2016.01); A23L 33/125 (2016.01); A23L 33/18 (2016.01)
CPC A23L 33/185 (2016.08) [A23L 33/115 (2016.08); A23L 33/125 (2016.08); A23L 33/18 (2016.08); A23L 33/40 (2016.08)] 20 Claims
OG exemplary drawing
 
1. A protein formulation, comprising:
(i) from at least greater than 35 wt % of a protein powder to 75 wt % of the protein powder, wherein said protein powder comprises an animal protein, wherein the protein powder has over 98 wt % of digestible protein as measured by a 0.2% pepsin test; and
(ii) greater than 10 wt % of fat by weight.